BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28258558)

  • 1. Metastatic breast cancer diagnosed by rubidium-82 positron emission tomography myocardial perfusion imaging.
    Shafiq A; Ammar KA; Gilles L; Machernis N; Mahlum D; Chareonthaitawee P; Port SC
    J Nucl Cardiol; 2018 Jun; 25(3):1048-1050. PubMed ID: 28258558
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidental mammary fibromyoblastoma on 82Rb myocardial perfusion imaging.
    Pelletier-Galarneau M; Martineau P; Davies RA
    Clin Nucl Med; 2015 Apr; 40(4):343-4. PubMed ID: 25546224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
    Erhamamci S; Reyhan M; Canpolat T; Nursal GN; Yapar AF
    Clin Nucl Med; 2016 Mar; 41(3):e146-8. PubMed ID: 26562574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
    Nielsen MØ; Schledermann H; Jensen LT
    J Nucl Cardiol; 2023 Oct; 30(5):2252-2253. PubMed ID: 36795296
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative Prognostic Significance of Positron Emission Tomography Myocardial Perfusion Imaging Markers in Cardiomyopathy.
    Thomas M; Sperry BW; Peri-Okonny P; Malik AO; McGhie AI; Saeed IM; Chan PS; Spertus JA; Thompson RC; Bateman TM; Patel KK
    Circ Cardiovasc Imaging; 2021 Oct; 14(10):e012426. PubMed ID: 34665673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of rubidium-82 positron emission tomography in patients after heart transplant.
    Mc Ardle BA; Davies RA; Chen L; Small GR; Ruddy TD; Dwivedi G; Yam Y; Haddad H; Mielniczuk LM; Stadnick E; Hessian R; Guo A; Beanlands RS; deKemp RA; Chow BJ
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):930-7. PubMed ID: 25182366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial perfusion in patients with suspected coronary artery disease: comparison between 320-MDCT and rubidium-82 PET.
    Dantas RN; Assuncao AN; Marques IA; Fahel MG; Nomura CH; Avila LFR; Giorgi MCP; Soares J; Meneghetti JC; Parga JR
    Eur Radiol; 2018 Jun; 28(6):2665-2674. PubMed ID: 29352381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients hold proton pump inhibitors prior to
    Al-Mallah MH
    J Nucl Cardiol; 2020 Oct; 27(5):1452-1455. PubMed ID: 32095936
    [No Abstract]   [Full Text] [Related]  

  • 9. Leaving relativity behind: quantitative clinical perfusion imaging.
    Bengel FM
    J Am Coll Cardiol; 2011 Aug; 58(7):749-51. PubMed ID: 21816312
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment.
    Ishihara K; Kobayashi Y; Iwano M; Shiiba M; Yoshihara H; Satoh H; Akiyama K; Kumita S
    J Nippon Med Sch; 2011; 78(5):272-3. PubMed ID: 22041872
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease: a preliminary study.
    Qayyum AA; Hasbak P; Larsson HBW; Christensen TE; Ghotbi AA; Mathiasen AB; Vejlstrup NG; Kjaer A; Kastrup J
    Eur J Radiol; 2014 Jul; 83(7):1120-1128. PubMed ID: 24815746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose 3D (82)Rb PET.
    Slomka PJ; Berman DS; Germano G
    J Nucl Cardiol; 2012 Dec; 19(6):1110-2. PubMed ID: 23129187
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac involvement from adenocarcinoma of the lung at diagnosis detected by (18)F-FDG-PET imaging.
    Basu S; Alavi A
    Hell J Nucl Med; 2008; 11(3):182. PubMed ID: 19081865
    [No Abstract]   [Full Text] [Related]  

  • 14. Pure mucinous breast carcinoma with lung metastasis in a young male patient.
    Kertmen N; Dogan E; Altundag K
    Am Surg; 2010 Aug; 76(8):E146. PubMed ID: 21513640
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting outcomes in heart transplantation: PET project or actionable data.
    Givertz MM
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):857-9. PubMed ID: 25406196
    [No Abstract]   [Full Text] [Related]  

  • 16. No major impact of prescribed CAD drugs on myocardial perfusion uptake derived by [
    Werner RA; Rowe SP; Higuchi T
    J Nucl Cardiol; 2022 Dec; 29(6):2863-2865. PubMed ID: 34611851
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal Adenosine Stress for Maximum Stress Perfusion, Coronary Flow Reserve, and Pixel Distribution of Coronary Flow Capacity by Kolmogorov-Smirnov Analysis.
    Kitkungvan D; Lai D; Zhu H; Roby AE; Johnson NP; Steptoe DD; Patel MB; Kirkeeide R; Gould KL
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28213449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-FDG PET/CT scan in malignant priapism with diffuse pulmonary adenocarcinoma metastatic invasion of both corpus spongiosum and cavernosum.
    Blanc E; Calais J; Cardot V; Mabille L
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):588-9. PubMed ID: 24346413
    [No Abstract]   [Full Text] [Related]  

  • 19. Rubidium-82 uptake in metastases from pheochromocytoma on PET myocardial perfusion images.
    Gupta A; DiFilippo FP; Brunken RC
    Clin Nucl Med; 2011 Oct; 36(10):930-1. PubMed ID: 21892051
    [No Abstract]   [Full Text] [Related]  

  • 20. Rubidium-82 cardiac positron emission tomography imaging: an overview for the general cardiologist.
    Dhar R; Ananthasubramaniam K
    Cardiol Rev; 2011; 19(5):255-63. PubMed ID: 21808169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.